Temsirolimus in renal cell carcinoma with sarcomatoid differentiation: A report of three cases

Medical Oncology

Volumn 29, Issue 2, 2012, Pages 795-798

  Areses, Maria Carmen ^a   Herranz, Urbano Anido ^a   Ferrán, Beatriz Bernárdez ^a   Mateos, Luis León ^a   González, Jorge Garcia ^a   López, Rafael López ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

Renal cell carcinoma; Sarcomatoid; Temsirolimus

Indexed keywords

BUPIVACAINE; FENTANYL; MORPHINE; TEMSIROLIMUS; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; RAPAMYCIN;

ABDOMINAL PAIN; ADULT; ANALGESIA; ARTICLE; ASTHENIA; BONE METASTASIS; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISTANT METASTASIS; DRUG ACTIVITY; DRUG WITHDRAWAL; EPIDURAL CATHETER; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY CARCINOMA; LUNG METASTASIS; LYMPH NODE DISSECTION; MALE; NEPHRECTOMY; PARAAORTIC LYMPH NODE; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOMATOID CARCINOMA; KIDNEY TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SIROLIMUS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84865687233     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-9976-y     Document Type: Article

References (17)

1. Delahunt B. Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies. Pathology. 1999;31(3):185-90.
2. Lohse CM, Cheville JC. A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma. Clin Lab Med. 2005;25(2):433-64.
3. Kuroda N, Toi M, Hiroi M, Enzan H. Review of sarcomatoid renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol. 2003;18(2):551-5.
4. Mian BM, Bhadkamkar N, Slaton JW, Pisters PW, Daliani D, Swanson DA, Pisters LL. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol. 2002; 167(1):65-70.
5. Kwak C, Park YH, Jeong CW, Jeong H, Lee SE, Moon KC, Ku JH. Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma. J Surg Oncol. 2007;95(4):317-23.
6. Bangalore N, Bhargava P, Hawkins MJ. Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: case report and review of the literature. Ann Oncol. 2001;12(2):271-4.
7. Rashid MH, Welsh CT, Bissada NK, Chaudhary UB. Complete response to Adriamycin and ifosfamide in a patient with sarcomatoid renal cell carcinoma. Am J Clin Oncol. 2005;28(1):107-8.
8. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med. 2007;356(22):2271-81.
9. Dutcher JP, de Souza P, McDermott D, Figlin RA, Berkenblit A, Thiele A, et al. Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies. Med Oncol. 2009;26(2):202-9.
10. Tickoo SK, Alden D, Olgac S, Fine SW, Russo P, Kondagunta GV, et al. Immunohistochemical expression of hypoxia inducible factor-1 alpha and its downstream molecules in sarcomatoid renal cell carcinoma. J Urol. 2007;177(4):1258-63.
11. Hammers HJ, Verheul HM, Salumbides B, Sharma R, Rudek M, Jaspers J, et al. Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: Evidence from a xenograft study. Mol Cancer Ther. 2010;9(6):1525-35.
12. Sosman JA, Puzanov I, Atkins MB. Opportunities and obstacles to combination targeted therapy in renal cell cancer. Clin Cancer Res. 2007;13(2 Pt 2):764s-9s.
13. Golshayan AR, George S, Heng DY, Elson P, Wood LS, Mekhail TM, et al. Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. J Clin Oncol. 2009;27(2):235-41.
14. Molina AM, Tickoo SK, Ishill N, Trinos MJ, Schwartz LH, Patil S, et al. Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease. Am J Clin Oncol. 2010. doi:10.1097/COC.0b013e3181f47aa4.
15. Dutcher JP, Nanus D. Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapy. Med Oncol. 2010. dio:10.1007/s12032-010-9649-2.
16. Nanus DM, Garino A, Milowsky MI, Larkin M, Dutcher JP. Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma. Cancer. 2004;101(7):1545-51.
17. Haas NB, Lin X, Manola J, Pins M, Liu G, McDermott D, et al. A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802. Med Oncol. 2011. doi:10.1007/s12032-011-9829-8.